SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-162064
Filing Date
2021-05-14
Accepted
2021-05-14 16:31:32
Documents
61
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d792214d10q.htm 10-Q 712056
2 EX-31.1 d792214dex311.htm EX-31.1 6380
3 EX-31.2 d792214dex312.htm EX-31.2 6331
4 EX-32.1 d792214dex321.htm EX-32.1 6339
  Complete submission text file 0001193125-21-162064.txt   3878356

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cfrx-20210531.xml EX-101.INS 780345
6 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20210531.xsd EX-101.SCH 36470
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cfrx-20210531_cal.xml EX-101.CAL 33076
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cfrx-20210531_def.xml EX-101.DEF 136836
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20210531_lab.xml EX-101.LAB 319090
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20210531_pre.xml EX-101.PRE 246696
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 21925186
SIC: 2834 Pharmaceutical Preparations